Electronic Journal of Liver Tumor ›› 2021, Vol. 8 ›› Issue (2): 53-56.

• Review • Previous Articles     Next Articles

Pathological diagnosis and treatment progress of hepatic epithelioid hemangioendothelioma

Liang Yiting, Shi Susheng   

  1. Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Caner Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021,China
  • Received:2021-03-31 Published:2021-07-16

Abstract: Hepatic epithelioid hemangioendothelioma(HEHE) is a rare vascular endothelial cell tumor, composed of epithelioid and histiocyte-like vascular endothelial cells in mucus or fibrotic stroma, and is low to moderately malignant. The etiology of HEHE is unclear. It can be characterized as single, multiple, or diffuse, and the multifocal form is most common. There is no specificity in imaging diagnosis including ultrasound, MRI, and CT. The diagnosis mainly depends on histopathology and immunohistochemical staining. Immunohistochemical antibodies include vascular endothelial markers CD31, CD34, CD10, D2-40, ERG, FLI-1, factorⅧ etc, and epithelial markers CD8/18, EMA, etc. Changes in molecular biology mainly include the WWTR1-CAMTA1 fusion gene, and a small number of YAP1-TFE3 fusion genes can be detected and diagnosed by FISH. Liver resection and liver transplantation are the preferred treatment methods for HEHE.

Key words: Epithelioid hemangioendothelioma, Liver, Pathological diagnosis, Treatment